Archive for August 10th, 2008
Buy Ipca Labs
Strong performance in branded finished dosages, growth momentum in exports and a strong position in anti-malarial drugs makes Ipca Labs, a medium sized pharma company with Rs 1,100 crore revenues, a good investment option.
At the current market price of Rs 567, the stock trades at 8 times its 2008-09 earnings per share; at a discount [...]


